CUBICIN is a lipopeptide antibacterial indicated for the treatment of: • Complicated skin and skin structure infections (cSSSI) (1.1) • Staphylococcus aureus. bloodstream infections...

Oct 24, 2023 · Cubicin is used to treat bacterial infections of the skin and underlying tissues, and infections that have entered the bloodstream. Cubicin is used for complicated infections, including MRSA or "super bug" infections .

Detailed dosage guidelines and administration information for Cubicin (daptomycin). Includes dose adjustments, warnings and precautions.

CUBICIN contains daptomycin, a cyclic lipopeptide antibacterial agent derived from the fermentation of Streptomyces roseosporus. The chemical name is N-decanoyl-L-tryptophyl-D...

Jul 22, 2024 · Cubicin package insert / prescribing information for healthcare professionals. Includes: indications, dosage, adverse reactions and pharmacology.

Jan 7, 2025 · Cubicin is a cyclic lipopeptide antibacterial agent with a broad spectrum of activity against Gram-positive bacteria, including methicillin-susceptible and -resistant Staphylococcus aureus (MSSA/MRSA) and vancomycin-resistant Enterococci (VRE).

Feb 10, 2025 · To reduce the development of drug-resistant bacteria and maintain the effectiveness of CUBICIN RF and other antibacterial drugs, CUBICIN RF should be used only to treat or prevent infections that are proven or strongly suspected to be …

Cubicin and Cubicin RF are both indicated for the treatment of complicated skin and skin structure infections (cSSSI) caused by susceptible strains of Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus (MRSA).

The Cubicin RF formulation of daptomycin reconstituted with sterile water for injection to yield a concentration of 50 mg/mL and pack- aged in polypropylene syringes with an elastomeric plunger stopper

CUBICIN® RF is indicated for the treatment of adult patients with Staphylococcus aureus bloodstream infections (bacteremia), including those with right-sided infective endocarditis, caused by...